Lv2
138 积分 2023-09-07 加入
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
4天前
已完结
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
2个月前
已完结
M-DODII: Bayesian dose optimization design for randomized phase II study with multiple indications
2个月前
已完结
Conditional and Unconditional Treatment Effects in Randomized Clinical Trials: Estimands, Estimation, and Interpretation
5个月前
已完结
皖公网安备34019202002308
